Fifty-seven patients ( 25 men ; mean age , 32 + / - 10.1 yr ) with quiescent steroid-dependent Crohn 's ileitis , ileocolitis , or colitis ( Crohn 's disease activity index < 150 ) entered a prospective , investigator-blind trial .
